|
TA385689
|
OriGene Technologies
|
CD52 [Campath-1H] Human Monoclonal Antibody
|
Human, Monkey
|
CT, ELISA, FC, IHC, WB
|
|
|
TA385692
|
OriGene Technologies
|
CD20 (MS4A1) [10F381 (rituximab)] Human Monoclonal Antibody
|
Human, Monkey
|
FC
|
|
|
TA385810
|
OriGene Technologies
|
IL2 Receptor alpha (IL2RA) [Daclizumab] Human Monoclonal Antibody
|
Human, Monkey
|
Bl, FC
|
|
|
TA385813
|
OriGene Technologies
|
IL2 Receptor alpha (IL2RA) [Basiliximab] Human Monoclonal Antibody
|
Human, Monkey
|
Bl, FC, IF, IHC, WB
|
|
|
TA386080
|
OriGene Technologies
|
CD22 [hL22 (Epratuzumab)] Human Monoclonal Antibody
|
Human, Monkey
|
Bl, FC, IP
|
|
|
TA386106
|
OriGene Technologies
|
CD40 [5D12] Human Monoclonal Antibody
|
Human, Cynomolgus, Monkey
|
Bl, ELISA, FC, IHC, IP
|
|
|
TA386530
|
OriGene Technologies
|
PD-L1 (CD274) [332M7] Human Monoclonal Antibody
|
Human, Mouse, Monkey
|
Bl, FC
|
|
|
TA399811
|
OriGene Technologies
|
CD3E [CD3B219] Human Monoclonal Antibody
|
Human, Monkey
|
FC
|
|
|
TA385689
|
OriGene Technologies
|
CD52 [Campath-1H] Human Monoclonal Antibody
|
Human, Monkey
|
CT, ELISA, FC, IHC, WB
|
|
|
TA385692
|
OriGene Technologies
|
CD20(MS4A1) [10F381(rituximab)] Human Monoclonal Antibody
|
Human, Monkey
|
FC
|
|
|
TA385810
|
OriGene Technologies
|
IL2Receptoralpha(IL2RA) [Daclizumab] Human Monoclonal Antibody
|
Human, Monkey
|
Bl, FC
|
|
|
TA385813
|
OriGene Technologies
|
IL2Receptoralpha(IL2RA) [Basiliximab] Human Monoclonal Antibody
|
Human, Monkey
|
Bl, FC, IF, IHC, WB
|
|
|
TA386080
|
OriGene Technologies
|
CD22 [hL22(Epratuzumab)] Human Monoclonal Antibody
|
Human, Monkey
|
Bl, FC, IP
|
|
|
TA386106
|
OriGene Technologies
|
CD40 [5D12] Human Monoclonal Antibody
|
Human, Cynomolgus, Monkey
|
Bl, ELISA, FC, IHC, IP
|
|
|
TA386530
|
OriGene Technologies
|
PD-L1(CD274) [332M7] Human Monoclonal Antibody
|
Human, Mouse, Monkey
|
Bl, FC
|
|
|
TA399811
|
OriGene Technologies
|
CD3E [CD3B219] Human Monoclonal Antibody
|
Human, Monkey
|
FC
|
|
